Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Selective targeting of the IL23 pathway: Generation and characterization of a novel high-affinity humanized anti-IL23A antibody.

Singh S, Kroe-Barrett RR, Canada KA, Zhu X, Sepulveda E, Wu H, He Y, Raymond EL, Ahlberg J, Frego LE, Amodeo LM, Catron KM, Presky DH, Hanke JH.

MAbs. 2015;7(4):778-91. doi: 10.1080/19420862.2015.1032491. Epub 2015 Apr 23.

2.

A proteomic analysis of the plasma glycoproteins of a MCF-7 mouse xenograft: a model system for the detection of tumor markers.

Orazine CI, Hincapie M, Hancock WS, Hattersley M, Hanke JH.

J Proteome Res. 2008 Apr;7(4):1542-54. doi: 10.1021/pr7008516. Epub 2008 Mar 13.

PMID:
18336003
3.

Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling.

McDermott U, Sharma SV, Dowell L, Greninger P, Montagut C, Lamb J, Archibald H, Raudales R, Tam A, Lee D, Rothenberg SM, Supko JG, Sordella R, Ulkus LE, Iafrate AJ, Maheswaran S, Njauw CN, Tsao H, Drew L, Hanke JH, Ma XJ, Erlander MG, Gray NS, Haber DA, Settleman J.

Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19936-41. Epub 2007 Dec 6.

4.

Protein biomarkers and drug design for cancer treatments.

Hanke JH, Webster KR, Ronco LV.

Eur J Cancer Prev. 2004 Aug;13(4):297-305. Review.

PMID:
15554558
5.

Expression of activated CDC42 induces T cell apoptosis in thymus and peripheral lymph organs via different pathways.

Na S, Li B, Grewal IS, Enslen H, Davis RJ, Hanke JH, Flavell RA.

Oncogene. 1999 Dec 23;18(56):7966-74.

7.

Appropriate developmental expression of human CD8 beta in transgenic mice.

Kieffer LJ, Yan L, Hanke JH, Kavathas PB.

J Immunol. 1997 Nov 15;159(10):4907-12.

PMID:
9366416
8.

Human CD8 alpha expression in NK cells but not cytotoxic T cells of transgenic mice.

Kieffer LJ, Bennett JA, Cunningham AC, Gladue RP, McNeish J, Kavathas PB, Hanke JH.

Int Immunol. 1996 Oct;8(10):1617-26.

PMID:
8921442
9.

D4-GDI, a substrate of CPP32, is proteolyzed during Fas-induced apoptosis.

Na S, Chuang TH, Cunningham A, Turi TG, Hanke JH, Bokoch GM, Danley DE.

J Biol Chem. 1996 May 10;271(19):11209-13.

10.

Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation.

Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, Pollok BA, Connelly PA.

J Biol Chem. 1996 Jan 12;271(2):695-701.

11.

Role of tyrosine kinases in lymphocyte activation: targets for drug intervention.

Hanke JH, Pollok BA, Changelian PS.

Inflamm Res. 1995 Sep;44(9):357-71. Review.

PMID:
8846193
12.
13.
14.

NonO, a non-POU-domain-containing, octamer-binding protein, is the mammalian homolog of Drosophila nonAdiss.

Yang YS, Hanke JH, Carayannopoulos L, Craft CM, Capra JD, Tucker PW.

Mol Cell Biol. 1993 Sep;13(9):5593-603.

15.

FK506 and rapamycin selectively enhance degradation of IL-2 and GM-CSF mRNA.

Hanke JH, Nichols LN, Coon ME.

Lymphokine Cytokine Res. 1992 Oct;11(5):221-31.

PMID:
1281674
16.

The ubiquitous octamer-binding protein(s) is sufficient for transcription of immunoglobulin genes.

Johnson DG, Carayannopoulos L, Capra JD, Tucker PW, Hanke JH.

Mol Cell Biol. 1990 Mar;10(3):982-90.

17.

Molecular cloning and DNA sequence analysis of the 37-kilodalton endoflagellar sheath protein gene of Treponema pallidum.

Isaacs RD, Hanke JH, Guzman-Verduzco LM, Newport G, Agabian N, Norgard MV, Lukehart SA, Radolf JD.

Infect Immun. 1989 Nov;57(11):3403-11.

18.

Identification of murine nuclear proteins that bind to the conserved octamer sequence of the immunoglobulin promoter region.

Hanke JH, Landolfi NF, Tucker PW, Capra JD.

Proc Natl Acad Sci U S A. 1988 May;85(10):3560-4.

19.

Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.

Maurer DH, Hanke JH, Mickelson E, Rich RR, Pollack MS.

J Immunol. 1987 Aug 1;139(3):715-23.

PMID:
3110281
20.

Differential antigen-presenting cell requirements of hapten-specific T cell lines restricted to class II determinants.

Hanke JH, Cook RG, Lopez LA, Rich RR.

J Immunol. 1987 Apr 15;138(8):2384-91.

PMID:
3494064
21.

Trinitrophenyl reactive T-cell clones in functional and molecular analysis of the HLA-D region.

Rich RR, Hanke JH, Cook RG.

Adv Exp Med Biol. 1987;225:43-54. Review.

PMID:
2455968
22.

Molecular characterization of a subtype of DQw1 recognized by hapten-specific T cells.

Hanke JH, Cook RG, Leone JW, Van M, Rich RR.

Immunogenetics. 1986;24(4):209-16.

PMID:
2877943
23.

Class II positive human dermal fibroblasts restimulate cloned allospecific T cells but fail to stimulate primary allogeneic lymphoproliferation.

Maurer DH, Collins WE, Hanke JH, Van M, Rich RR, Pollack MS.

Hum Immunol. 1985 Nov;14(3):245-58.

PMID:
3932267
24.

Class II determinants recognized by TNP-specific cloned human T cell lines.

Hanke JH, Brown MF, Pollack MS, Rich RR.

Hum Immunol. 1985 Sep;14(1):59-76.

PMID:
2411702

Supplemental Content

Loading ...
Support Center